Market cap
$2.129 B
$16.57 +6.49%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
-$108.0M
Loss-making
Shares outstanding
128,475,440
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Precision Instruments — ranked by market cap
All 3 →Where these numbers come from
Share counts and financials for Neogenomics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.